Date: 2025/03/15 - 15:32
An orange a day, regular moderate-to-vigorous exercise, and GLP-1 drugs for diabetes treatment have all been linked to a lower risk of depression in recent studies.
Date: 2025/03/13 - 11:00
Nonsteroidal anti-inflammatory drug use for over 2 years was associated with a lower risk for dementia, especially Alzheimer's disease, in a recent study.
Date: 2025/03/01 - 16:00
In a study of thousands of people with dementia, researchers found that treatment with antidepressants was linked to faster cognitive decline — though certain medications appeared to have a greater impact than others.
Date: 2025/02/25 - 21:00
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.
Date: 2025/02/23 - 11:31
Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.
Date: 2025/02/21 - 21:31
A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer insights on new preventive and therapeutic avenues?
Date: 2025/02/18 - 20:34
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for weight loss, and supplements for heart health.
Date: 2025/02/18 - 17:31
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using GLP-1 drugs such as Ozempic and Wegovy after losing weight.
Date: 2025/02/17 - 20:00
Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use disorder, a new study suggests.
Date: 2025/02/15 - 11:31
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than those other diabetes drugs.